- Filed
- May 23, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · May 23, 2022 | 9.42M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2022 | 9.41M sh |
| Shares Diluted restated | Q1 2022 · Mar 31, 2021 | 15.39M sh |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $80.63K |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $773.42K |
| Cash And Equivalents | Q1 2022 · Mar 31, 2021 | $3.79K |
| Cash And Equivalents | Q1 2022 · Dec 31, 2020 | $36.52K |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $9.69M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $9.2M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $9.96M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $9.47M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $306.08K |
| Current Assets | Q1 2022 · Dec 31, 2021 | $930.04K |
| Total Assets | Q1 2022 · Mar 31, 2022 | $504.94K |
| Total Assets | Q1 2022 · Dec 31, 2021 | $1.1M |
| Eps Basic | Q1 2022 · Mar 31, 2022 | −$0.12 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | $6.27 |
| Capex | Q1 2022 · Mar 31, 2021 | $0 |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$171.35K |
| Stockholders Equity | Q1 2022 · Mar 31, 2021 | −$10.71M |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | −$12.46M |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | −$0.02 |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $261.39K |
| Rd Expense | Q1 2022 · Mar 31, 2021 | $13.52K |
| Net Income | Q1 2022 · Mar 31, 2021 | $1.74M |
| Operating Income | Q1 2022 · Mar 31, 2021 | −$237.46K |
| Gross Profit | Q1 2022 · Mar 31, 2021 | $37.45K |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $37.86K |
| Revenue | Q1 2022 · Mar 31, 2021 | $75.31K |